Europe Automated Breast Ultrasound Systems Market Size to exceed USD 328.0 Mn by 2024

 Request a sample

According to the Graphical Research new growth forecast report titled “Europe Automated Breast Ultrasound Systems (ABUS) Market analysis based on Product, End-Use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024”, estimated to exceed USD 328.0 million by 2024.

Rising awareness about breast cancer screening coupled with growing number of initiatives to promote breast cancer awareness will spur Europe automated breast ultrasound systems market growth. Breast cancer screening program (BCSP) was extensively implemented for early breast cancer screening in Russia. The program offers screening at 2-year intervals to women between 40 to 60 years of age. Such initiatives are estimated to impel the adoption of ABUS in recent years.

Restricted capability of mammography systems to diagnose breast cancer in dense breast tissues will positively impact ABUS business growth. ABUS assists in detecting small tumors at early stage of breast cancer that can significantly reduce treatment cost due to early diagnosis. Various studies have proved superlative detection rate of ABUS over mammography system. Thus, superior screening and detection rate over mammography system will drive demand for automated imaging modalities in foreseeable years.

However, high cost of ABUS devices along with irregular and non-uniform reimbursement scenario can hamper Europe automated breast ultrasound market growth during the projected period.

Automated breast ultrasound system segment held significant market size of USD 51.1 million in 2017. Higher detection rate of breast cancer than mammography systems increases the customer preference for ABUS. In addition, enhanced or large field of view of breast and decreased time for generating breast images contribute to the benefits, that will result into segmental expansion over the coming years.

Diagnostic imaging centers segment will grow at rapid pace of 13.0% CAGR. Growing healthcare spending on cancer treatment for patients in Europe will offer attractive opportunity for segmental expansion. Implementation of national screening program in the region will further stimulate segmental share in foreseeable years.

France ABUS market will foresee rapid growth at 12.9% CAGR over the forecast timeframe. Growing incidence of breast cancer coupled with rising initiatives to promote breast cancer screening will positively impact market growth. For instance, free national screening program are organized for women aged between 50 and 74 years of age. Above factors will augment France ABUS industry growth in upcoming years.

Few of the established market players in Europe automated breast ultrasound systems market are GE Healthcare, Hitachi Ltd., Koninklijke Philips N.V., Siemens AG, SonoCine Inc., and Theraclion. Industry players are concentrating efforts on strategic alliances such as agreements, mergers and acquisitions for fortifying market presence and for capturing profits. For instance, in July 2016, Royal Philips strategically partnered with Andalusian Health Service, Spain. Partnership with various hospitals ensures installation, integration, maintenance, and updates of medical technologies provided by the firm in order to achieve optimal delivery of care.

Segments we Cover:

Europe Automated Breast Ultrasound Systems Market By Product

  • Automated Breast Ultrasound System
  • Automated Breast Volume Scanner
  • Others

Europe Automated Breast Ultrasound Systems Market By End-use

  • Hospitals
  • Diagnostic Imaging Centers

The above information is provided for the following region and countries:

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Ukraine
  • Switzerland
  • Belgium
  • Austria
  • Czech Republic
  • Netherlands
  • Sweden